MedPath

NEKKAR LAB SRL

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone

Not Applicable
Recruiting
Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
Combination Product: MARIAL® + PPI (generic Omeprazole)
Drug: PPI alone (generic omeprazole)
Device: MARIAL® alone
First Posted Date
2019-10-17
Last Posted Date
2023-12-15
Lead Sponsor
Nekkar Lab Srl
Target Recruit Count
110
Registration Number
NCT04130659
Locations
🇮🇹

UOC Endoscopia Digestiva Chirurgica Policlinico Gemelli - Universita Cattolica, Roma, Italy

🇷🇴

Cabinet Particular Policlinic Algomed, Timișoara, Timis, Romania

🇷🇴

Societatea Civilă Medicală Gados, Timişoara, Romania

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.